Related Experiment Video
Updated: Jun 19, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint
Yong Y Kim1, Linda Von Weymarn, Ola Larsson
1Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA. kimxx327@umn.edu
Abstract:
The usurping of translational control by sustained activation of translation initiation factors is oncogenic. Here, we show that the primary negative regulators of these oncogenic initiation factors--the 4E-BP protein family--operate as guardians of a translational control checkpoint in lung tumor defense. When challenged with the tobacco carcinogen 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone (NNK), 4ebp1(-/-)/4ebp2(-/-) mice showed increased sensitivity to tumorigenesis compared with their wild-type counterparts. The 4E-BP-deficient state per se creates pro-oncogenic, genome-wide skewing of the molecular landscape, with translational activation of genes governing angiogenesis, growth, and proliferation, and translational activation of the precise cytochrome p450 enzyme isoform (CYP2A5) that bioactivates NNK into mutagenic metabolites. Our study provides in vivo proof for a translational control checkpoint in lung tumor defense.
Insights
The 4E-BP protein family acts as a crucial checkpoint in lung tumor defense by regulating translation. Loss of 4E-BP proteins increases lung cancer risk and promotes tumor growth by activating oncogenic genes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Sustained activation of translation initiation factors can drive oncogenesis.
- The 4E-BP protein family are key negative regulators of these factors.
- Understanding translational control is vital for cancer defense.
Purpose of the Study:
- To investigate the role of the 4E-BP protein family in lung tumor defense.
- To determine the impact of 4E-BP deficiency on tumorigenesis in response to a carcinogen.
- To elucidate the molecular mechanisms underlying 4E-BP's function in lung cancer.
Main Methods:
- Utilized a mouse model deficient in 4E-BP1 and 4E-BP2 (4ebp1(-/-)/4ebp2(-/-)).
- Exposed mice to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
- Analyzed genome-wide molecular changes, including gene expression and translational control.
Main Results:
- 4ebp1(-/-)/4ebp2(-/-) mice exhibited increased sensitivity to NNK-induced tumorigenesis compared to wild-type mice.
- A 4E-BP-deficient state promoted pro-oncogenic molecular alterations.
- Demonstrated translational activation of genes involved in angiogenesis, growth, and proliferation.
- Showcased translational activation of CYP2A5, an enzyme that bioactivates NNK.
Conclusions:
- The 4E-BP protein family functions as guardians of a translational control checkpoint in lung tumor defense.
- Loss of 4E-BP proteins creates a pro-oncogenic environment, enhancing susceptibility to lung cancer.
- This study provides in vivo evidence for a critical role of translational control in preventing lung tumorigenesis.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Leaky Scanning

